CD8A and lymphoma: Analysis of infiltrating immune populations in EL-4 lymphomas showed that α-PD-1/α-PD-L1 treatment did not affect MDSC, T or NK cell accumulation but slightly increased the fraction of CD8+ T cells displaying an effector phenotype (Supplementary Fig. 6a–e).